Found 7 matching trials
Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults
PHASE1This study is designed to characterize the safety and immunogenicity of a' ...
Location
GSK Investigational Site
Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)
PHASE3The primary purpose of the study is to assess the equivalence of the immune...
Location
GSK Investigational Site
Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years
PHASE2The purpose of this study is to show that vaccination with a single dose of...
Location
GSK Investigational Site
Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old
PHASE1This study will assess safety and immunogenicity of GSK Biologicals' H5N1 f...
Location
GSK Investigational Site
Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age
PHASE3The purpose of this study is to characterize the safety and efficacy of GSK...
Location
GSK Investigational Site
Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults
PHASE2This study is designed to characterize the safety and immunogenicity of a' ...
Location
Multiple Locations
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)
PHASE2This trial will assess the immunogenicity and safety elicited by the adjuva...
Location
GSK Investigational Site